Focused networks in eye care, cancer, fertility (IVF), mother & child, orthopaedics and dental - smaller centres, repeatable formats.
Dr Agarwal's Health CareOperator · HighListed
Rainbow Children's MedicareOperator · HighListed
HealthCare Global Enterprises (HCG)Operator · HighListed
ShalbyOperator · HighListed
Indira IVFOperator · HighUnlisted
Cloudnine HospitalsOperator · HighUnlisted
Where it fits
Runs one specialty in a standard format that can be copied city to city: eye hospitals and clinics, cancer centres with radiation and day-care chemo, IVF clinics, paediatric and maternity hospitals, orthopaedic and joint-replacement centres. Many use hub-and-spoke networks, partner doctors and asset-light leases.
Why it matters
Specialty formats need less capital per rupee of revenue than a multi-specialty hospital, scale faster and attract private equity: eye care, IVF and oncology have seen most of the sector's recent buyouts (KKR in HCG, EQT in Indira IVF, TPG and Temasek in Dr Agarwal's). They are also more exposed to cash patients and price competition.
Where the value pool sits
High-teens to high-20s EBITDA margins for mature centres; much of the spending is cash or partly insured (cataract and IVF are often out-of-pocket). Growth comes from new centres in tier-2/3 towns and from higher-value procedures (premium lenses, robotic joint replacement, advanced radiation).
Key drivers
Ageing (cataract, joint replacement, cancer) and later parenthood (IVF)
Insurance now covering more day-care and specialty procedures
Private-equity capital funding roll-ups of regional specialty chains
Potential bottlenecks
Specialist doctors (oncologists, fertility specialists, paediatric intensivists) are scarce outside metros
Expensive equipment (linear accelerators, PET-CT) for oncology
Regulation of IVF/ART clinics under the ART Act 2021 and surrogacy rules